NCT02538302View on ClinicalTrials.gov

Minirin Versus Oxybutynin for Nocturnal Enuresis in Children

PHASE3CompletedINTERVENTIONAL
Enrollment

66

Participants

Timeline

Start Date

July 31, 2013

Primary Completion Date

July 31, 2015

Study Completion Date

August 31, 2015

Conditions
Nocturnal Enuresis
Interventions
DRUG

Minirin

Minirin 5 to 10 mg daily for 6 months

DRUG

Oxybutynin

Oxybutynin 5 to 10 mg daily for 6 months

Trial Locations (1)

79176

Shahid Mohammadi hospital, Bandar Abbas

All Listed Sponsors
lead

Hormozgan University of Medical Sciences

OTHER

NCT02538302 - Minirin Versus Oxybutynin for Nocturnal Enuresis in Children | Biotech Hunter | Biotech Hunter